To access publisher's full text version of this article, please click on the hyperlink in Additional Links field or click on the hyperlink at the top of the page marked FilesThere are major challenges ahead for clinicians treating patients with atrial fibrillation (AF). The population with AF is expected to expand considerably and yet, apart from anticoagulation, therapies used in AF have not been shown to consistently impact on mortality or reduce adverse cardiovascular events. New approaches to AF management, including the use of novel technologies and structured, integrated care, have the potential to enhance clinical phenotyping or result in better treatment selection and stratified therapy. Here, we report the outcomes of the 6th Conse...
© 2021 The Author(s). This is an open-access article distributed under the terms of the Creative Com...
Atrial fibrillation (AF) is the most common sustained arrhythmia in the general population. As an ag...
In 2014, a joint consensus document dealing with the management of antithrombotic therapy in atrial ...
There are major challenges ahead for clinicians treating patients with atrial fibrillation (AF). The...
There are major challenges ahead for clinicians treating patients with atrial fibrillation (AF). The...
There are major challenges ahead for clinicians treating patients with atrial fibrillation (AF). The...
There are major challenges ahead for clinicians treating patients with atrial fibrillation (AF). The...
At least 30 million people worldwide carry a diagnosis of atrial fibrillation (AF), and many more su...
Aims Despite marked progress in the management of atrial fibrillation (AF), detecting AF remains dif...
There are major challenges ahead for clinicians treating patients with atrial fibrillation (AF). The...
The management of atrial fibrillation (AF) has seen marked changes in past years, with the introduct...
AIMS: As health systems around the world increasingly look to measure and improve the value of care ...
Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/142234/1/joa3369.pd
© 2021 The Author(s). This is an open-access article distributed under the terms of the Creative Com...
Atrial fibrillation (AF) is the most common sustained arrhythmia in the general population. As an ag...
In 2014, a joint consensus document dealing with the management of antithrombotic therapy in atrial ...
There are major challenges ahead for clinicians treating patients with atrial fibrillation (AF). The...
There are major challenges ahead for clinicians treating patients with atrial fibrillation (AF). The...
There are major challenges ahead for clinicians treating patients with atrial fibrillation (AF). The...
There are major challenges ahead for clinicians treating patients with atrial fibrillation (AF). The...
At least 30 million people worldwide carry a diagnosis of atrial fibrillation (AF), and many more su...
Aims Despite marked progress in the management of atrial fibrillation (AF), detecting AF remains dif...
There are major challenges ahead for clinicians treating patients with atrial fibrillation (AF). The...
The management of atrial fibrillation (AF) has seen marked changes in past years, with the introduct...
AIMS: As health systems around the world increasingly look to measure and improve the value of care ...
Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/142234/1/joa3369.pd
© 2021 The Author(s). This is an open-access article distributed under the terms of the Creative Com...
Atrial fibrillation (AF) is the most common sustained arrhythmia in the general population. As an ag...
In 2014, a joint consensus document dealing with the management of antithrombotic therapy in atrial ...